Jazz Pharma director transfers 5,000 shares in divorce
Jazz Pharmaceuticals plc director Patrick Enright reported a transfer of 5,000 Ordinary Shares on 08/18/2025.
Rhea-AI Filing Summary
Jazz Pharmaceuticals plc director Patrick Enright reported a transfer of 5,000 Ordinary Shares on 08/18/2025. The Form 4 shows this was a code J transaction, with a footnote explaining the shares were transferred to a former spouse without any payment as part of a comprehensive division of marital assets. After this transfer, Enright beneficially owned 21,379 Ordinary Shares, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Ordinary Shares | 5,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Jazz Pharmaceuticals (JAZZ) disclose in this Form 4?
The Form 4 reports that director Patrick Enright transferred 5,000 Ordinary Shares of Jazz Pharmaceuticals plc on 08/18/2025 in a code J transaction.
What does transaction code J mean in this JAZZ Form 4 filing?
Transaction code J in this context indicates an acquisition or disposition that is other than a typical open-market trade; here, it reflects a share transfer related to a marital asset division.
AI-generated analysis. How Rhea-AI works. Not financial advice.